4//SEC Filing
Nichols David Wayne 4
Accession 0000899243-21-036595
CIK 0001690585other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 5:00 PM ET
Size
5.4 KB
Accession
0000899243-21-036595
Insider Transaction Report
Form 4
Nichols David Wayne
Chief Technical Officer
Transactions
- Sale
Common Stock
2021-09-16$6.73/sh−5,694$38,321→ 14,306 total
Footnotes (2)
- [F1]This transaction represents shares sold solely to pay taxes due upon the vesting of restricted stock units, as disclosed by the reporting person on the Form 4 filed on September 16, 2021.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.60 to $6.87, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001857488
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 5:00 PM ET
- Size
- 5.4 KB